Manuel Aivado files SEC Form 4 disclosures for AILERON THERAPEUTICS INC. They have made 1 open-market trade across 1 company since 2018, most recently 2018-06-06.
CIK 0001709603
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALRN | 1,000 | $2K |
Shares reported on the most recent Form 4, priced at the 2018-06-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALRN | BUY | 2018-06-06 | 2018-06-08 | $5.61 | $6K | -2.2% | +0.0% | -37.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.